TiGenix Potential Therapy for Crohn’s-related Perianal Fistulas Gets FDA Approval
News
The U.S. Food and Drug Administration (FDA) has granted TiGenix orphan drug designation for its lead candidate Cx601, which aims to treat perianal fistulas caused by Crohn’s disease in patients who have ... Read more